← Back to all substances
A triple monoamine reuptake inhibitor developed by Hoffman-LaRoche in the 1970s as an antidepressant but discontinued, probably due to high abuse potential. Has not become popular as a recreational drug at this time. Acts as an SNDRI, mostly inhibits dopamine and noradrenaline.
Dosage
Oral
Common: 40-60mg
Heavy: 60-80mg
Light: 30-40mg
Threshold: 12-15mg
NOTE: These doses are tentative and may need further research.
Duration
Duration: 4-6 hours
Timeline
Peak
4-6 hours
03h6h
Typical
Extended range